Tokyo, Japan

Daishiro Ikeda

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 5.5

ph-index = 5

Forward Citations = 71(Granted Patents)


Location History:

  • Tokyo, JP (1984 - 2016)
  • Tokyo-To, JP (2012 - 2016)

Company Filing History:


Years Active: 1984-2016

Loading Chart...
Loading Chart...
18 patents (USPTO):

Title: The Innovative Contributions of Daishiro Ikeda

Introduction

Daishiro Ikeda, a prominent inventor based in Tokyo, Japan, has made significant strides in the field of antibacterial agents. With a total of 13 patents to his name, he is recognized for his inventive spirit and dedication to addressing bacterial infections, particularly those caused by resistant strains.

Latest Patents

Ikeda's latest patents include developments in Desalaninebenanomicin A derivatives and processes for their preparation. He has also focused on dibekacin derivatives and arbekacin derivatives that are active against resistant bacteria. Notable innovations include new dibekacin derivatives such as 2'-amino-2'-deoxydibekacin and 2'-amino-5,2'-dideoxydibekacin, as well as arbekacin derivatives like 2'-amino-2'-deoxyarbekacin and 2'-amino-5,2'-dideoxyarbekacin. These compounds exhibit high antibacterial activity against a broad range of gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus, while also maintaining low toxicity to mammals. This makes them valuable as antibacterial agents for treating bacterial infections.

Career Highlights

Throughout his career, Daishiro Ikeda has worked with esteemed organizations, including the Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai and Bristol-Myers Squibb Company. His contributions in these roles have greatly advanced the development of effective antibacterial solutions.

Collaborations

Ikeda’s innovative endeavors have also been supported by fruitful collaborations with notable colleagues, including Shinichi Kondo and Tomio Takeuchi. Their joint efforts have fostered a dynamic research environment that encourages the continued advancement of antibacterial agents and related technologies.

Conclusion

Daishiro Ikeda's dedication to innovation, combined with his extensive patent portfolio, positions him as a significant figure in antibacterial research. His latest advancements continue to hold promise for combating resistant bacterial infections, contributing positively to public health. As he continues to innovate, the impact of his work is likely to expand further, benefiting both science and society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…